You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Effectuez un dépistage du virus de l'hépatite B chez tous les patients cancéreux débutant un traitement systémique. Apprenez-en davantage sur le dépistage et la gestion du virus de l'hépatite B.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Que contient le nouveau formulaire de médicaments

Vous trouverez ici toutes les monographies de médicaments et de régimes nouvelles et récemment mises à jour, ainsi que les fiches de renseignements sur les patients et les documents de sécurité et de conseils.

Regimen
Published Date: 07 Aug 2025
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Premedication and Supportive Measures section, added link to T-Cell Engaging Antibody Guideline.

Aug 2025
Regimen
Published Date: 07 Aug 2025
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Premedication and Supportive Measures section, added link to T-Cell Engaging Antibody Guideline.

Aug 2025
Drug

Published Date: 07 Aug 2025

Revision Summary:
Drug Monograph: Updated Adverse Effects, Dosing, Administration, Warnings and Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline.
Patient Info Sheet EN: Updated patient information sheet
Aug 2025
Regimen
Published Date: 07 Aug 2025
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Funding information, Premedication and Supportive Measures, Dose Modifications, Drug Administration and Special Precautions, and Recommended Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline

Aug 2025
Regimen
Published Date: 06 Aug 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated drug regimen section

Aug 2025
Regimen
Published Date: 05 Aug 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Revision Summary:
Patient Info Sheet EN: New patient medication information sheet
Aug 2025
Regimen
Published Date: 05 Aug 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Revision Summary:
Patient Info Sheet EN: Revised patient regimen information sheet.
Aug 2025
Regimen
Published Date: 01 Aug 2025
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses and Supplementary Public Funding sections

Aug 2025
Regimen
Published Date: 01 Aug 2025
Cancer Type:
Genitourinary, 
Prostate
Intent: Curative, Palliative
Revision Summary:

Regimen Monograph: Updated Intent, Rationale/Uses, Supplementary Public Funding, Drug Regimen, Cycle Frequency, and Administration sections

Aug 2025
Drug

Published Date: 01 Aug 2025

Revision Summary:
Drug Monograph: Updated Supplementary Public Funding section
Aug 2025
Drug

Published Date: 01 Aug 2025

Revision Summary:
Drug Monograph: Updated Dosing, Administration and Supplementary Public Funding sections
Aug 2025
Regimen
Published Date: 31 Jul 2025
Cancer Type:
Hematologic, 
Leukemia - Chronic Myeloid (CML)
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated to a full regimen monograph

Jul 2025

Pages